𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Family history of cancer and the risk of prostate cancer and benign prostatic hyperplasia

✍ Scribed by Eva Negri; Claudio Pelucchi; Renato Talamini; Maurizio Montella; Silvano Gallus; Cristina Bosetti; Silvia Franceschi; Carlo La Vecchia


Publisher
John Wiley and Sons
Year
2005
Tongue
French
Weight
76 KB
Volume
114
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

We analysed the relation between family history of cancer in first‐degree relatives and risk of prostate cancer (PC) and benign prostatic hyperplasia (BPH) using data from a multicentric case‐control study conducted in Italy from 1991 to 2002 on 1,294 cases of incident, histologically confirmed PC, 1,369 cases of BPH and 1,451 men admitted to the same network of hospitals for acute, nonneoplastic conditions. Unconditional logistic regression was used to estimate odds ratios (OR) of PC and BPH, adjusted for age and other confounders. Men with a family history of PC had an OR of PC of 4.0 (95% confidence interval [CI] 2.5–6.5), and the risk was higher when the proband was younger, when 2 or more relatives were affected or when the affected relative was a brother. The risk of PC was also increased in men with a family history of cancer of the ovary (OR = 6.2, 95% CI 1.2–32), bladder (OR = 3.5, 95% CI 1.6–7.4) and kidney (OR = 3.1, 95% CI 1.1–8.5). An involvement of breast/ovarian cancer predisposition genes in a small proportion of PCs was suggested by the cluster of these cancers in female relatives of a few PC cases. The risk of BPH was increased in men with a family history of bladder cancer (OR = 2.2, 95% CI 1.0–5.0) but not PC (OR = 1.2, 95% CI 0.7–2.2). Our study adds further information on the association of family history of cancer and risk of PC and is, to our knowledge, the first comprehensive epidemiologic information on family history of cancer and risk of BPH. Β© 2004 Wiley‐Liss, Inc.


πŸ“œ SIMILAR VOLUMES


Leptin in relation to prostate cancer an
✍ Pagona Lagiou; Lisa B. Signorello; Dimitrios Trichopoulos; Anastasia Tzonou; Ant πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 French βš– 44 KB πŸ‘ 2 views

The aim of our study was to determine whether leptin, a hormone implicated in both energy-balance and reproductive function, is involved in the etiology of prostate cancer or benign prostatic hyperplasia (BPH). We compared the serum leptin levels of 43 cases of incident prostate cancer, 41 patients

Impact of age, benign prostatic hyperpla
✍ Rinaa S. Punglia; Anthony V. D'Amico; William J. Catalona; Kimberly A. Roehl; Ka πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 195 KB πŸ‘ 1 views

## Abstract ## BACKGROUND The distribution of prostate‐specific antigen (PSA) values for men with or without prostate carcinoma are confounded because of verification bias. Correcting for verification bias, the means and variances of PSA values were estimated in specific clinical scenarios. ## ME

Family history of prostate cancer and pr
✍ Jiyoung Ahn; Roxana Moslehi; Stephanie J. Weinstein; Kirk Snyder; Jarmo Virtamo; πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 French βš– 94 KB πŸ‘ 1 views

## Abstract Prostate cancer family history has been associated with increased risk of the malignancy. Most prior studies have been retrospective and subject to recall bias, however, and data evaluating interactions with other important risk factors are limited. We examined the relationship between